Evidence for an angiotensin receptor in esophageal smooth muscle of the opossum.
D000802:Angiotensin Amide / Q000494:pharmacology; D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004943:Esophagogastric Junction / Q000294:innervation / Q000378:metabolism*; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009538:Nicotine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011945:Receptors, Angiotensin / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism*; D012504:Saralasin / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology; D014630:Vagus Nerve / Q000502:physiology*; D014700:Verapamil / Q000494:pharmacology
D006584:Hexamethonium Compounds; D011945:Receptors, Angiotensin; D011956:Receptors, Cell Surface; D000804:Angiotensin II; D010656:Phenylephrine; D013779:Tetrodotoxin; D000802:Angiotensin Amide; D009538:Nicotine; D001285:Atropine; D014700:Verapamil; D012504:Saralasin; D010646:Phentolamine